Home
Conditions
Glioblastoma

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,502 public trials 307 recruiting studies

Refine in advanced search Browse all conditions

Glioblastoma trial results

Completed

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

NCT00003463

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

NCT00544284

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +40 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

NCT00008008

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +21 more
Locations: St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

NCT00017147

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States

Banner Good Samaritan Medical Center Phoenix, Arizona, United States

CCOP - Western Regional, Arizona Phoenix, Arizona, United States

St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View all 163 locations

View Trial Details

Completed

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

NCT00354913

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma

NCT00005082

Conditions: Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +18 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

NCT00190424

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Hopital Salpetriere Paris, France

Hopital Lariboisiere Paris, France

View Trial Details

Completed

Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00274833

Conditions: Astrocytoma, CNS Tumor, Adult, Central Nervous System Neoplasms, +13 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

NCT00613054

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Glioblastoma

Glioblastoma trial results

Related conditions